Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin prophylaxis in high-risk hematologic patients
ChiCTR-PNC-11001575Phase 4Completed
- Sponsor
- Shanghai General Hospital
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of micafungin in invasive mycoses, sponsored by Shanghai General Hospital. Primary endpoint: Incidence of possible invasive fungal infection during prophylaxis, at end of prophylaxis, and 1 week after prophylaxis. Started Jul 2011; status: completed.
02
Drugs
micafungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR-PNC-11001575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PNC-11001575.